(Q24236588)

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Fatalities due to anaphylactic reactions to foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Further fatalities caused by anaphylactic reactions to food, 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Emergency department anaphylaxis: A review of 142 patients in a single year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Clinical features and severity grading of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Latex allergy in dentistry. Review and report of case presenting as a serious reaction to latex dental dam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Multicenter study of emergency department visits for food allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Multicenter study of emergency department visits for insect sting allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Biphasic systemic anaphylaxis: an inpatient and outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

National study of US emergency department visits for acute allergic reactions, 1993 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Fatal anaphylaxis: postmortem findings and associated comorbid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Time trends in allergic disorders in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis: a review of causes and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Biphasic anaphylactic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990 -2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Adrenaline in the treatment of anaphylaxis: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis in the United States: an investigation into its epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Lessons for management of anaphylaxis from a study of fatal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Further fatal allergic reactions to food in the United Kingdom, 1999-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Symposium on the definition and management of anaphylaxis: summary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Incidence and characteristics of biphasic reactions after allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Advances in H1-antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis, killer allergy: long-term management in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis: Recent advances in assessment and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Emergency treatment of anaphylactic reactions--guidelines for healthcare providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Anaphylaxis: a review of 601 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

Adrenaline for the treatment of anaphylaxis with and without shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

Biphasic and protracted anaphylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

Fatal posture in anaphylactic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

Evidence-based management of anaphylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021

A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007596.PUB2

7 January 2021